The FDA has warned that ketamine and compounded ketamine products aren’t approved to take care of any psychiatric disorder. This means that they haven’t been verified to get Harmless or effective. In 2019, the FDA approved a nasal spray called esketamine (Spravato) that’s derived from ketamine for treatment-resistant depression, but only in s… Read More